Skip to main content
LOGIN
Providers
Life Sciences
Resources
All Resources
Blog
Case Studies
Education
CME
News and Events
About
About Us
Meet Our Leadership Team
Meet Our Board of Directors
Awards
Careers
Contact Us
Schedule A Demo
Providers
Life Sciences
Resources
Project ECHO® Learning Series
Evolving Role of Bispecific Antibodies as Cancer Therapy
Join ACCC, Physicians' Education Resource (PER), and Pharmacy Times Continuing Education (PTCE) for a five-part complimentary tele-mentoring series on the optimal use of bispecific antibodies as cancer immunotherapies.
VIEW RECORDED SESSIONS
OncoLens Resources
All Resources
Blog
Case Studies
Education
CME
News and Events
About
OncoLens provides a first of its kind
multidisciplinary care platform.
More than 10% of all cancer centers in the United States count on OncoLens to help improve outcomes through coordinated patient data, in-depth analysis, and actionable clinical decision support.
3,000,000+
Oncology patients under care within the network
85-90%
Accuracy in AI-driven Patient ID from unstructured data
250,000+
Multidisciplinary case discussions
About OncoLens
About Us
Meet Our Leadership Team
Awards
Meet Our Board of Directors
Contact Us
Careers
Schedule a Demo
Contact Us
Schedule Demo
LOGIN
OncoLens
Resources
ALL
Blog
Case Studies
CME
Education
News and Events
1
2
3
4
5
Dec 06, 2022 | News and Events
ACCC and Boston University Present the Project ECHO® Eight-Part Webinar Series, Powered by OncoLens
Read More
Nov 28, 2022 | CME
Project ECHO®: Endocrine Toxicities with Immune Checkpoint Inhibitors
Read More
Oct 25, 2022 | CME
Project ECHO®: Gastroenterology Toxicities with Immune Checkpoint Inhibitors
Read More
Sep 22, 2022 | News and Events
Women-Led Digital Health: The Women Behind Digital Health Innovations and the Journey to Success
Read More
Sep 20, 2022 | CME
Project ECHO®: Cardiovascular Toxicities with Immune Checkpoint Inhibitors
Read More
Aug 26, 2022 | CME
Project ECHO® Learning Series: Telementoring to Manage Immune-Related Adverse Events in Patients Receiving Cancer Immunotherapies
Read More
Jul 19, 2022 | News and Events
MIB Agents Selects OncoLens to Support and Expand its TURBO Program Globally
Read More
May 12, 2022 | CME
Optimizing Frontline Immunotherapy in Advanced Non-Small Cell Lung Cancer
Read More
Mar 15, 2022 | Education
Quality Improvement Program Webinar—Breast and Ovarian Cancer Biomarker Testing
Read More
Mar 08, 2022 | Education
Quality Improvement Program Webinar—NSCLC Biomarker Testing
Read More
Feb 04, 2022 | News and Events
The Desmoid Tumor Research Foundation Closes Care Gaps through Virtualized Multidisciplinary Cancer Care Platform
Read More
Jan 20, 2022 | News and Events
OncoLens Platform Critical to Meeting the CoC’s Continuous Quality Improvement Requirements
Read More
Dec 27, 2021 | Blog
2022 Multidisciplinary Cancer Care Top Five Trends
Read More
Dec 17, 2021 | News and Events
OncoLens Celebrates the CoC’s 100th Anniversary
Read More
Sep 24, 2021 | Case Studies
Results of a Multi-State, Multi-Institution Implementation of a Multidisciplinary Conference Quality Measurement Tool
Read More
Aug 17, 2021 | News and Events
New Markey Initiative Helps Affiliates Deliver Cancer Care Closer to Home
Read More
Jun 04, 2021 | Case Studies
Time-Saving Opportunities through Tumor Board and Cancer Registry Integration
Read More
Jun 01, 2021 | CME
Molecular Testing in the Community Oncology Setting
Read More
Apr 01, 2021 | Education
Lung Cancer Patient with 3 EGFR Mutations
Read More
Apr 01, 2021 | Education
Ovarian Cancer Patient with Somatic BRCA1 Reversion Mutation
Read More
Apr 01, 2021 | Education
Ovarian and Lung Cancer Patients with BRCA Reversion and Three EGFR Mutations
Read More
1
2
3
4
5
3903
